8EHQ-11-18297A TSCA 8(e) Notice

First Page		Document Content
Date: 2012-07-24 13:56:30 Pulmonary alveolus Amines Toxic Substances Control Act Atelectasis Celanese Formaldehyde Lung Methadone Emphysema Anatomy Chemistry Medicine		8EHQ-11-18297A TSCA 8(e) Notice Add to Reading List Source URL: www.epa.gov Download Document from Source Website File Size: 560,79 KB Share Document on Facebook

	Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality Please note, this report is designed for double-sided printing DocID: 1rXbZ - View Document
	BMS_2016_Inflammation_emphysema_Fibrosis_2016.pdf DocID: 1nVzq - View Document
	Pulmonx Gets FDA Nod for U.S. Trial of Emphysema Therapy IDE for Study of Zephyr® Endobronchial Valve Approved August 27, 2012, Redwood City, CA, USA, Pulmonx, an emerging leader in interventional pulmonology, announced DocID: 1lQgn - View Document
	Treatment Options Literature 1. Sciurba F et al. A randomized study of endobronchial valves for advanced emphysema. N Eng J Med 2010;363:. Felix J.F. Herth, Marc Noppen, Arschang Valipour, Sylvie Leroy,Jean-M DocID: 1lEMB - View Document
	Patient Guide PCEN12/11_01 Endobronchial Valve Treatment of Emphysema Patients DocID: 1llqd - View Document